4th June 2025
28th May 2025
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
28th May 2025
Aktis Oncology Initiates Phase 1b Clinical Trial Of Its Nectin-4- Targeting Radiopharmaceutical Product Candidate, Aky-1189, Across Multiple Tumor Types
13th October 2023
GBR’s USA Life Sciences 2023 Report featuring Chris Bardon
10th October 2023
AstronauTx Closes $61M Series A to Create New Alzheimer’s Treatments
28th September 2023
Deka Biosciences Closes USD $20 Million Series B2 Financing
21st September 2023
The Endpoints 11: Biotech Startups With the Most Exciting Science
19th September 2023
ReCode Therapeutics Announces Closing of Extension to Series B Financing
2nd August 2023
Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement
11th May 2023